Efficacy of cholecystojejunostomy and choledochoenterostomy for obstructive jaundice caused by unresectable pancreatic head carcinoma: a meta-analysis

doi:10.3877/cma.j.issn.2095-3232.2016.04.004

Abstract

Abstract:

Objective

To investigate the efficacy of cholecystoenterostomy (CCE) and choledochoenterostomy (CDE) for obstructive jaundice caused by unresectable pancreatic head carcinoma.

Methods

Literature from the Cochrane, PubMed, EMBASE, Ovid, Springer, CNKI, WANFANG, VIP databases between January 1980 and January 2016 was searched. The search terms were pancreatic cancer, pancreatic neoplasms, pancreatic tumor, cholecystoenterostomy, choledochoenterostomy, biliary bypass and palliative surgery, both in Chinese and English. The patients from the literature were divided into the CCE group and CDE group. The outcome indicators including recurrence rate of jaundice, perioperative mortality and incidence of postoperative complications in two groups were analyzed using the Meta-analysis.

Results

A total of 12 literatures were included after screening, including two reports of random controlled trials and 10 retrospective studies. The meta-analysis results revealed that the recurrence rate of jaundice in the CCE group was significantly higher than that in the CDE group (OR=5.00, 95%CI: 3.12-8.03; P<0.05). The median survival time in the CCE group was significantly shorter than that in the CDE group (SMD=-1.96, 95%CI: -2.30 - -1.62; P<0.05). The perioperative mortality in the CCE group was significantly higher than that in the CDE group (OR=1.90, 95%CI:1.56- 2.23; P<0.05).

Conclusion

Compared with CCE, CDE has the advantages of lower recurrence rate of jaundice, lower perioperative mortality and longer survival time in treating obstrucive jaundice caused by unresectable pancreatic head carcinoma.

Key words: Pancreatic neoplasms, Jaundice,obstructive, Cholecystoenterostomy, Choledochoenterostomy, Meta-analysis

Xu Chang, Peng Liu, Jing Zhang, Haidong Bao, Peng Gong. Efficacy of cholecystojejunostomy and choledochoenterostomy for obstructive jaundice caused by unresectable pancreatic head carcinoma: a meta-analysis[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2016, 05(04): 214-220.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3232.2016.04.004

https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/Y2016/V05/I04/214

Figures/Tables 6

References 34

[1]	陈万青，张思维，郑荣寿，等．中国肿瘤登记地区2007年肿瘤发病和死亡分析[J]．中国肿瘤，2011, 20(3): 162-169.
[2]	杜灵彬，余传定，汪祥辉，等．浙江省四个肿瘤登记地区2006年恶性肿瘤发病率与死亡率分析[J]．中华肿瘤防治杂志，2010，17(16): 1244-1248.
[3]	Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths[J]. CA Cancer J Clin, 2011, 61 (4): 212-236.
[4]	Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database[J]. J Am Coll Surg, 1999, 189(1): 1-7.
[5]	Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5): 277-300.
[6]	Li D, Xie K, Wolff R, et al. Pancreatic cancer[J]. Lancer, 2004, 363 (9414): 1049-1057.
[7]	Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. a prospective, single-institution experience[J]. Ann Surg, 1997, 225 (5): 621-633.
[8]	Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial[J]. Gastrointest Endosc, 2006, 63(7): 986-995.
[9]	House MG, Choti MA. Palliative therapy for pancreatic/biliary cancer[J]. Surg Clin North Am, 2005, 85 (2):359-371.
[10]	Simes RJ. Confronting publication bias: a cohort design for meta-analysis[J]. Stat Med, 1987, 6(1): 11-29.
[11]	张克兰，黎有典，陈能志，等．胰头癌的外科治疗：附142例报告[J]．中国普通外科杂志，2009, 18(3): 268-271.
[12]	乔森．胰头癌姑息手术治疗86例[J]．腹部外科，2005, 18(5): 279-280.
[13]	陶开山，窦科峰，李开宗，等．胰头癌姑息性手术术式选择探讨[J]．中国普通外科杂志，2000, 9(2): 152-154.
[14]	刘宇斌，区金锐，简志祥，等．中晚期胰腺癌的外科治疗对策[J]．实用医学杂志，2004, 20(11): 1264-1266.
[15]	杨汉新，赵努庆．姑息性手术治疗不能切除的胰头癌[J]．中国普通外科杂志，1994, 3(4): 215-217.
[16]	张建军，王小平．胰头癌阻塞性黄疸的临床治疗分析[J]．中国实用医药，2012, 7(36): 83-84.
[17]	李焱宁，李定明．胰头癌姑息性手术中内引流的术式比较[J]．实用医学杂志，2005, 21(14): 1536-1537.
[18]	Urbach DR, Bell CM, Swanstrom LL, et al. Cohort study of surgical bypass to the gallbladder or bile duct for the palliation of jaundice due to pancreatic cancer[J]. Ann Surg, 2003, 237(1): 86-93.
[19]	Sarfeh IJ, Rypins EB, Jakowatz JG, et al. A prospective, randomized clinical investigation of cholecystoenterostomy and choledochoenterostomy[J]. Am J Surg, 1988,155 (3): 411-414.
[20]	Huguier M, Baumel H, Manderscheid JC, et al. Surgical palliation for unresected cancer of the exocrine pancreas[J]. Eur J Surg Oncol,1993, 19(4):342-347.
[21]	Rosemurgy AS, Burnett CM, Wasselle JA. A comparison of choledochoenteric bypass and cholecystoenteric bypass in patients with biliary obstruction due to pancreatic cancer[J]. Am Surg, 1989, 55(1): 55-60.
[22]	Rappaport MD, Villalba M. A comparison of cholecysto- and choledochoenterostomy for obstructing pancreatic cancer[J]. Am Surg, 1990, 56(7): 433-435.
[23]	王存德，龚泉，张利娟，等．恶性肿瘤姑息治疗的进展[J]．中国肿瘤，2012, 21(3): 206-210.
[24]	Schiavon AB, Muniz RM, Azevedo NA, et al. Health workers coping with having a relative in palliative care for cancer[J]. Rev Gaucha Enferm, 2016, 37(1): e55080.
[25]	Carter DC. Cancer of the pancreas[J]. Gut, 1990, 31(5): 494-496.
[26]	Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? a prospective randomized trial[J]. Ann Surg, 1999, 230(3): 322-328.
[27]	Singh SM, Longmire WP Jr, Reber HA. Surgical palliation for pancreatic cancer. the UCLA experience[J]. Ann Surg, 1990, 212(2): 132-139.
[28]	Moss AC, Morris E, Mac Mathuna P. Palliative biliary stents for obstructing pancreatic carcinoma[J]. Cochrane Database Syst Rev,2006 (2): CD004200.
[29]	Maire F, Hammel P, Ponsot P, et al. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas[J]. Am J Gastroenterol,2006,101(4):734-742.
[30]	Kuhlmann KF, De Castro SM, Gouma DJ. Surgical palliation in pancreatic cancer[J]. Minerva Chir, 2004, 59(2):137-149.
[31]	Taylor MC, McLeod RS, Langer B. Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: a meta-analysis[J]. Liver Transpl, 2000, 6(3): 302-308.
[32]	Gillen S, Schuster T, Friess H, et al. Palliative resections versus palliative bypass procedures in pancreatic cancer--a systematic review[J]. Am J Surg, 2012, 203(4):496-502.
[33]	Gillen S, Schuster T, Meyer Zum Büschenfelde C, et al. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages[J]. PLoS Med, 2010 ,7(4): e1000267.
[34]	赵玉沛，徐徕，丛林．胰腺癌新辅助治疗的现状与展望[J/CD]．中华普外科手术学杂志：电子版，2011, 5(1):1-6.

Please choose a citation manager

Content to export